Therapeutic potential of third-generation chimeric antigen receptor T cells targeting B cell maturation antigen for treating multiple myelomaPunchita Rujirachaivej(Mahidol University), Pa‐thai Yenchitsomanus(Siriraj Hospital)Clinical and Experimental MedicineApril 29, 202410.1007/s10238-024-01347-7Cited by 4SaveCiteExport RISWatch citationsRelated PapersAnti-mucin 1 chimeric antigen receptor T cells for adoptive T cell therapy of cholangiocarcinoma|Scientific Reports|2021|63Cordycepin exhibits both antiviral and anti-inflammatory effects against dengue virus infection|iScience|2024|15Dual action effects of ethyl-p-methoxycinnamate against dengue virus infection and inflammation via NF-κB pathway suppression|Scientific Reports|2024|9